Fibroblast Growth Factor-23 and Incident Atrial Fibrillation
نویسندگان
چکیده
منابع مشابه
Effect of High Intensity Interval Training on the Level of Atrial Fibrillation, Fibroblast Growth Factor 23 and Klotho Protein in Male Rats with Renal Failure
Introduction: Cardiovascular problems and atrial fibrillation is one of the most prevalent secondary consequences in hemodialysis patients. This study aimed to examine the effect of high intensity interval training on the level of atrial fibrillation, fibroblast growth factor 23 and Klotho in male rats with chronic kidney disease. Methods: In this study, 30 male rats Wistar (7-8 weeks) were ra...
متن کاملFibroblast growth factor 23: a novel key to find hidden substrates of atrial fibrillation?
Department t o o of f f Ph Ph Phys ys ysio io iolo lo logy gy a a and nd n C C Cel el e l l Bi Bi B ol ol olog og ogy y y
متن کاملCirculating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence.
BACKGROUND Atrial fibrillation (AF) occurs more frequently among patients with renal dysfunction. We investigated the possible association between prevalence of AF and serum fibroblast growth factor 23 (FGF23), which has been shown to be increased in subjects with renal dysfunction. METHODS AND RESULTS Among the total enrollment of 851 cardiac patients, 188 patients had AF (paroxysmal AF, 95;...
متن کاملFibroblast Growth Factor - 23 and Incident Atrial Fibrillation : The Multi - Ethnic Study of Atherosclerosis ( MESA ) and the Cardiovascular Health Study ( CHS ) Running title :
Division of Cardiology, University of Washington, Seattle, WA; Division of Nephrology and Kidney Research Institute, University of Washington, Seattle, WA; Cardiovascular Health Research Unit, Depts of Medicine and Epidemiology, University of Washington, Seattle, WA; Dept of Epidemiology, University of Washington, Seattle, WA; Dept of Laboratory Medicine, University of Washington, Seattle, WA; ...
متن کاملFibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).
BACKGROUND Fibroblast growth factor-23 (FGF-23) is a hormone that promotes urinary phosphate excretion and regulates vitamin D metabolism. Circulating FGF-23 concentrations increase markedly in chronic kidney disease and are associated with increased risk of clinical cardiovascular events. FGF-23 may promote atrial fibrillation (AF) by inducing left ventricular hypertrophy and diastolic and lef...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2014
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circulationaha.113.005499